Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egido

Showing results (841-850 of 1,068) with videos related to

Pageof 107
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2018
TWEAK and RIPK1 mediate a second wave of cell death during AKIDiego Martin-Sanchez, Miguel Fontecha-Barriuso, Susana Carrasco, et al.
Journal of the American Society of Nephrology : JASN|July 8, 2020
TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal DiseaseSandra Rayego-Mateos, Jose Luis Morgado-Pascual, José Manuel Valdivielso, et al.
The American Journal of Cardiology|June 24, 2008
Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndromeAlmudena Gómez-Hernández, Eva Sánchez-Galán, Mónica Ortego, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
TWEAKing renal injuryAna Belen Sanz, Juan Antonio Moreno, Maria Dolores Sanchez-Nino, et al.
Journal of Cardiovascular Pharmacology|January 21, 2006
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilizationAlmudena Gómez-Hernández, Eva Sánchez-Galán, José Luis Martín-Ventura, et al.
Journal of Pediatric Hematology/Oncology|October 23, 2020
Complications of Central Venous Access Devices in Patients With Sickle Cell Disease and Thalassemia MajorJavier Ordóñez, Agustín Del Cañizo, Cristina Beléndez, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 1, 2010
Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilationMahmut Ilker Yilmaz, Juan Jesús Carrero, Jose Luis Martín-Ventura, et al.
Journal of Molecular Cell Biology|August 10, 2013
Connective tissue growth factor is a new ligand of epidermal growth factor receptorSandra Rayego-Mateos, Raquel Rodrigues-Díez, Jose Luis Morgado-Pascual, et al.
Journal of Visualized Experiments : Jove|November 3, 2016
Phenotypic Characterization of Macrophages from Rat Kidney by Flow CytometryAlfonso Rubio-Navarro, Melania Guerrero-Hue, Beatriz Martín-Fernandez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 26, 2009
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout miceBegoña Muñoz-García, Juan Antonio Moreno, Oscar López-Franco, et al.
Pageof 107

Showing results (841-850 of 1,068) with videos related to

Sort By:
Pageof 107
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2018
TWEAK and RIPK1 mediate a second wave of cell death during AKIDiego Martin-Sanchez, Miguel Fontecha-Barriuso, Susana Carrasco, et al.
Journal of the American Society of Nephrology : JASN|July 8, 2020
TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal DiseaseSandra Rayego-Mateos, Jose Luis Morgado-Pascual, José Manuel Valdivielso, et al.
The American Journal of Cardiology|June 24, 2008
Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndromeAlmudena Gómez-Hernández, Eva Sánchez-Galán, Mónica Ortego, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
TWEAKing renal injuryAna Belen Sanz, Juan Antonio Moreno, Maria Dolores Sanchez-Nino, et al.
Journal of Cardiovascular Pharmacology|January 21, 2006
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilizationAlmudena Gómez-Hernández, Eva Sánchez-Galán, José Luis Martín-Ventura, et al.
Journal of Pediatric Hematology/Oncology|October 23, 2020
Complications of Central Venous Access Devices in Patients With Sickle Cell Disease and Thalassemia MajorJavier Ordóñez, Agustín Del Cañizo, Cristina Beléndez, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 1, 2010
Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilationMahmut Ilker Yilmaz, Juan Jesús Carrero, Jose Luis Martín-Ventura, et al.
Journal of Molecular Cell Biology|August 10, 2013
Connective tissue growth factor is a new ligand of epidermal growth factor receptorSandra Rayego-Mateos, Raquel Rodrigues-Díez, Jose Luis Morgado-Pascual, et al.
Journal of Visualized Experiments : Jove|November 3, 2016
Phenotypic Characterization of Macrophages from Rat Kidney by Flow CytometryAlfonso Rubio-Navarro, Melania Guerrero-Hue, Beatriz Martín-Fernandez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 26, 2009
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout miceBegoña Muñoz-García, Juan Antonio Moreno, Oscar López-Franco, et al.
Pageof 107